In primary rat cortical neurons, σ2R/TMEM97 was found as a therapeutic target for inhibition of the uptake of neurotoxic peptide Aβ42, whose accumulation and aggregation cause plaque formation and neurodegeneration in Alzheimer’s disease [69]. Here, TMEM97 is linked to early-onset autosomal dominant Alzheimer disease.